NCT05335512Not yet recruiting
Intravesical BCG: is the Urinary Bladder Ready to Receive it
Source: ClinicalTrials.gov · Last updated 9 Jun 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Prospective cohort and Prospective observational study which aims To define the healing time-frame of the resected area of the bladder after TURBT. and also to validate a grading system of healing of the bladder mucosa after TURBT. To assess the factors influencing bladder healing is also one of the secondary objectives.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 12 Apr 2022
- Start date
- 1 Sept 2022
- Primary completion date
- 1 Sept 2023
- Lead sponsor
- Tata Memorial Centre
- Diseases
- Bladder cancer
- NCT number
- NCT05335512
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Sept 2022 to the primary completion date, 1 Sept 2023
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- On histopathology found to have muscle invasive bladder cancer.
- Patient having urinary tract infection before cystoscopy
Other
- Patient who has visible tumor on first or any subsequent cystoscopy.
Who the study is looking for
- Patients undergoing complete TURBT for evaluation of a newly diagnosed bladder lesion in TMH and found to have NMIBC (either low risk or high risk) Patient gives consent will be included (after explaining about the study).
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.